Case Study:
Patient Identification for Faster Treatment
Patient Identification for Faster Treatment
Sometimes conditions that are not rare diseases still offer the same types of challenges in some situations. Sometimes finding the patients can be like finding a needle in a haystack. This product was in oncology but offered the same challenges as a rare disease drug in terms of finding the patients.
The Client Problem
• Had a 3rd Line Cancer product and many patients died at 2L so the 3L patients were rare and difficult to find
• Turned to Eularis to see if AI could identify and recruit more patients
The Solution
• Use big data (EHR and claims) and AI to:
◦ Identify and examine all previous 3L patients to predict what it was that increased probability of a patient reaching 3L+
◦ Identify the 2L patients who had the greatest probability of progressing
◦ Identify who their physicians were
◦ Created a visualization of all potential patient locations and could pull up doctor ID and other data on physician to allow the sales reps to prioritize who they saw
The Outcome
• Identified all possible 3L patients found in the EHR
• Were able to notify rep about the patient and physician even before they knew the patient would be 3L
• Were able to ensure that the physician was ready for the patients when they did progress and was aware of the benefits of the client drug for those situations where it was clinical appropriate
To achieve these kinds of results, contact Eularis today.
Latest News
Read our latest blogs here.
AI + Smart Devices: The New Frontline Against Chronic Disease
Chronic diseases have emerged as one of the most significant public health challenges of the 21st century. According to the World Health Organization, chronic diseases
What Blockchain Means for Health Record Data
Collecting and analysing information about our world is the best tool we have for solving big problems, be they environmental, social, or medical. Large datasets
Revolutionizing Biological AI with Diverse Data
In recent years, the convergence of artificial intelligence and biology has sparked a revolutionary transformation in the life sciences. As AI technology integrates with biological